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Atherosclerotic intracranial arterial stenosis is one of
the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke.
Symptomatic severe stenoses are at particularly high
risk of recurrent stroke despite medical management
[1]. Therefore, relative limitations of the medical
management have encouraged the development of new
strategies, such as endovascular treatment. Currently,
endovascular therapy is increasing in popularity in the
treatment of symptomatic intracranial atherosclerosis.
The Wingspan and Gateway percutaneous translumi-
nal angioplasty balloon system(Stryker Neurovascular,
Fremont, CA, U.S.A.), which widens a narrowed
intracranial artery, is the only system currently
approved by the U.S. Food and Drug Administration
for certain high-risk stroke patients. The Wingspan
stent is designed to be self-expandable and more
flexible to accommodate fragile brain arteries.
However, in several published cohorts, the periproce-
dural complication rate, including stroke, hemorrhage,
and vessel rupture, ranged from 4.5 to 14.7% [2-4].
In-stent thrombosis (IST) is considered as one of
important complication of the Wingspan. It is
commonly revealed in acute or subacute phase, and it
can lead to devastating results. Therefore, prompt and
effective management of IST is essential to achieve
patient’s cure. 
We present a case that acute IST after deployment of
a Wingspan stent was successfully managed with
another self-expandable stent without using a glycopro-
tein IIb/IIIa receptor antagonist or fibrinolytic agent.
CASE REPORT
A  66-year-old  female  was  presented  to  the
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Coincidental Occurrence of Acute In-stent
Thrombosis and Iatrogenic Vessel Perforation
During a Wingspan Stent Placement:
Management with a Stent In-stent Technique
Sun Joo Lee, MD, Hee Sup Shin, MD, Seung Hwan Lee, MD, Jun Seok Koh, MD
We presented a case that an acute in-stent thrombosis after the deployment of a Wingspan stent was
successfully managed with a stent in-stent technique. Because vessel perforation and subarachnoid hem-
orrhage were iatrogenically developed during the procedure, we were unable to use the thrombolytic
agents to correct the in-stent thrombosis. When a thrombotic complication following an intracranial
stent placement occurs with a coincidentally hemorrhagic complication, the stent in-stent technique
should be considered as a treatment option.
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http://dx.doi.org/10.5469/neuroint.2012.7.1.40emergency room with sudden weakness on her left side
and dysarthria while taking aspirin. She had already
suffered a transient ischemic attack 3 days ago.
Diffusion weighted magnetic resonance imaging (MRI)
showed several small acute infarctions scattered in her
right frontal cortex and basal ganglia. MR angiography
revealed a severe stenosis of the right middle cerebral
artery (MCA). Digital subtraction angiography (DSA)
confirmed the severe long segment stenosis of the
MCA and a significant decrease of flow velocity to the
distal segment (Fig. 1A). We suspected that her current
medical treatment would be ineffective to prevent
another stroke, and thus, we planned an endovascular
treatment. An endovascular procedure was performed 1
week later when her left-sided weakness was almost
recovered. She received a daily oral administration of
325 mg of aspirin and 75 mg of clopidogrel before the
procedure.
Endovascular procedure was performed under local
anesthesia and with systemic heparinization. With a 6
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Fig. 1. A. Right internal carotid angiogram demonstrating a moderate stenosis of proximal M1 (arrowhead) and severe stenosis of distal
M1 (arrow).
B. Following angioplasty and stenting with 3.5×20 mm Wingspan system, a significant recanalization of stenotic segment with minimal
residual stenosis is shown.
C. Subtle extravasation of contrast media (arrowheads) at an angular portion of the lateral sulcus is shown on the lateral right carotid
angiogram.
D. Rotating flat panel CT revealing a small amount of extravasation of contrast media and subarachnoid hemorrhage at the right lateral
sulcus and parietal sulci. ContinuedFr guiding catheter located in the right internal carotid
artery (ICA), a 010 microcatheter, and a 0.014-inch
microguidewire was navigated into the MCA. After the
microcatheter was advanced across the lesion, the
microwire was exchanged with a 300 cm exchange
wire that could facilitate balloon and stent navigation.
The microcatheter was removed, and a 1.5×20 mm
gateway balloon catheter was advanced over the
exchange wire. The balloon was located within the
stenotic segment and inflated to approximately 6 atm.
On control angiogram after balloon angioplasty,
stenotic MCA segment was partially recanalized. Next,
the Wingspan delivery system was prepared and
advanced over the exchange wire across the target
lesion. During Wingspan (3.5× 20 mm) passed
cavernous ICA, patient complained headache and
nausea, and systolic blood pressure was elevated from
normal  range  to  approximately  160  mmHg.
Immediately, a stent was deployed at the stenotic
segment and a control angiogram was achieved.
Although the stenotic segment was recanalized and the
distal flow restored to normal velocity (Fig. 1B), a tiny
irregularity of posterior parietal branch of right MCA
and extravasation of contrast media suggested that
dissections were revealed (Fig. 1C). Rotational flat
panel CT was performed immediately and showed a
small amount of extravasation of contrast media within
the subarachnoid space along the right lateral sulcus
(Fig. 1D). We dropped the blood pressure under normal
range and reversed heparin with protamine sulfate. On
the angiogram performed 10 minutes later, a small
filling defect appeared within the stenosis, which was
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Fig. 1. E. 30-minute delayed angiogram demonstrating multifocal
acute in-stent thrombosis, which compromises the flow to distal
branches of right middle cerebral artery (MCA).
F. Solitaire stent (4×20 mm) is deployed within the Wingspan
stent to manage the acute in-stent thrombosis. Arrow denotes
distal markers of Solitaire stent.
G. 30-minute delayed angiogram after 2nd stent deployment,
thrombosis within the Wingspan stent is resolved, and MCA is
reopened. suspected as IST. Thirty minutes later, growing
thrombus reduced the flow velocity of MCA (Fig. 1E),
and neurologic examination showed left-sided hemiple-
gia. Because of a subarachnoid hemorrhage caused by
an iatrogenic vessel injury, IIb/IIIa receptor antagonist
or fibrinolytic agent should not be administrated for
thrombolysis. To manage the IST, we considered a
mechanical recanalization using a stent in-stent
technique. Rebar 18” microcatheter (ev3, Irvine, CA,
U.S.A.) was passed the Wingspan stent, and a Solitaire
stent (4×20 mm, ev3, Irvine, CA, U.S.A.) was
deployed to cover the Wingspan stent (Fig. 1F). Post-
procedural angiogram revealed that the thrombosed
segment was partially recanalized. IST was completely
resolved on DSA obtained at 30 and 60 minutes after
procedure (Fig. 1G), and her neurologic deficit had
almost fully recovered. Brain CT at immediate and 24
hours after procedure did not reveal any new low
attenuation  or  progression  of  subarachnoid
hemorrhage. Seven days later, she was discharged
without developing neurological sequelae.
DISCUSSION
In-stent restenosis occurs in approximately 30% of
patients after delivery of the Wingspan stent, although
many of these incidents of re-stenosis remain asympto-
matic [5]. There has been little literature on acute IST
following a Wingspan stent placement. Although the
actual rate of periprocedural IST of intracranial stent is
not obvious, the most recent report demonstrated that
the rate of acute or subacute IST after intracranial stent
ranged from10% to 14.6% [4, 6]. Contrary to chronic
in-stent stenosis, acute IST can result in permanent
disability of the patient. 
The etiology of acute IST is not fully understood. It is
suspected to be associated with aspirin or clopidogrel
resistance. Asprin and clopidogrel resistance occur in
approximately 17% of patients undergoing coronary
stent [7]. Aspirin and clopidogrel resistance may be the
actual causes of IST during the periprocedural period,
but it is likely there are other factors that have not been
elucidated yet. It should be noted that the incidence of
IST in the Wingspan and Gateway system is more
frequent than that in the stent for aneurysm neck
remodeling. The reason can be explained that the
underlying disease itself is different from cerebral
aneurysms and may be more prone to acute thrombus
formation. A balloon angioplasty before the Wingspan
placement may result in an endothelial injury or the
exposure of atheromatous plaque material, promoting
an in-stent thrombus formation [4]. 
The present case showed that the secondary self-
expandable stent had resolved acute IST without a new
thrombus formation within the stent in spite of the non-
administration of fibrinolytic agents. The second stent
would open circumferentially to displace the thrombus,
immediately reestablishing a channel of flow within the
occluded vessel. Once antegrade flow was restored,
thrombus dissolution via endogenous thrombolysis
would follow stent deployment. Therefore, we
suspected that the etiology of acute IST in our case
might be not associated with aspirin or clopidogel
resistance but with endothelial injury. Stent in-stent
would cover the exposure plaque material from the
coagulation system, protecting re-growth of the
thrombus within stent. Unfortunately, we were unable
to confirm drug resistance using blood assay, such as
VerifyNow
� P2Y12 Test.
The management described for the IST includes a
systemic or local application of IIb/IIIa receptor
antagonist or a recombinant tissue-type plasminogen
activator with/without balloon angioplasty [4, 6, 8].
Although these thrombolytic agents are effective
solutions for acute thrombolysis, they cannot be used
and the mechanical technique should be considered for
the recanalization of thrombotic occlusion of artery
when there is a recent hemorrhage such as the present
case. We have found several reports regarding the use
of stent-in stent technique for recanalization of the late
in-stent restenosis following the Wingspan placement
[5, 8, 9]. However, to the best of our knowledge, this
present case is the first case that has recanalized acute
IST using a stent in-stent technique and without using
the thrombolytics. 
Iatrogenic vascular perforation is a complication of
major concern that can result in fatal intracranial
hemorrhages during endovascular neurointervention.
The rate of vascular perforation related to neurointer-
ventions within the largest series was 1.1% [10]. When
vascular perforation is detected during a procedure, the
treatment should immediately begin with a reversal of
anticoagulant, lowering the blood pressure and/or
temporary or permanent closure of the ruptured vessel. 
As in this case, when an IST following a Wingspan
stent placement for intracranial stenosis occurs with a
coincidentally hemorrhagic complication, the deploy-
ment of another stent in-stent should be considered as a
treatment option.   
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